Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for prevention of carboprost-induced nausea and vomiting during cesarean section
ChiCTR2100049983Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in nausea ((none)) and Vomiting (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoints: Incidence and severity of nausea and Incidence and severity of vomiting. Planned start Aug 2021; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
nausea ((none))Vomiting
Beyond the preview
Go deeper on ChiCTR2100049983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100049983.